CureVac Strengthens Ongoing Patent Litigations

 

• Cases in Germany and the U.S. broadened by asserting additional, new intellectual property rights
• Three new intellectual property rights added to infringement lawsuit against Pfizer/BioNTech in Germany, increasing number of asserted intellectual property rights to eight
• Tenth patent added to CureVac's counterclaim against Pfizer/BioNTech in the U.S., covering innovations in mRNA purification methods highly relevant to the manufacturing of Comirnaty®

https://www.biospace.com/article/releases/curevac-strengthens-ongoing-patent-litigations-bringing-additional-cases-under-new-intellectual-property-rights/